Tiziana Life Sciences Share Discussion Threads

[stenick] 02/1/2019 13:36

Happy new year Jp. Looking forward to some good trial results especially Foralumab’s potency.I thought the nasdaq would do better :-( but at least they got the money to carry on.Onwards and up :-).

[jpuff] 02/1/2019 05:29

Happy New year to all holders keeping the faith. Let's hope it's a good one for us all. Regards JP

[jpuff] 26/11/2018 08:24

What are folk on here doing regarding possible conversion of aim listed shares into ADS's re today's news. No need to as such but what are the benefits or drawbacks anyone? Cheers

[stenick] 22/11/2018 09:26

93p on nasdaq, shares released on aim on 23rd. DYOR.

[stenick] 31/10/2018 10:54

Registration of shares on Nasdaq now filed. Here we go. But I suppose it will be another long wait for more news.At least they are not tight for money now.

[wageslave] 18/10/2018 11:57

£16 million in shares being sold vs a market cap of 132m. So should not be a massive dilution.

[asmodeus] 18/10/2018 10:13

Yes, I noticed that, and thought I must be mistaken.... but sadly not, the share price is down 17.9% (to about 100p), already.

[osammyboy2] 18/10/2018 09:24

Nice offer for the Americans 75p a share. Wouldn't mind a share of that though looks like we might get down to that soon

[osammyboy2] 28/9/2018 19:54

An offer like that for TILS would give us about 5 Euro, or £4 per share. I'll take that. Anybody got contacts at Roche?

[jpuff] 28/9/2018 16:50

Up to 655 million euro for a pre-clinical companyHTTps://www.tusktherapeutics.com/HTTps://globenewswire.com/news-release/2018/09/28/1586258/0/en/Tusk-Therapeutics-to-be-acquired-by-Roche.html

[wageslave] 26/9/2018 09:54

Antibody biotech Tiziana Life Sciences sets terms for $16 million Nasdaq IPORenaissance Capital, September 25, 2018, 09:30:00 AM EDT  Tiziana Life Sciences, which is developing antibody therapies to combat NASH, Crohn's disease, MS, and cancer, announced terms for its Nasdaq IPO on Tuesday. The London, United Kingdom-based company plans to raise $16 million by offering 1.575 million ADSs at $10.25, the as-converted price of its shares on London's AIM (symbol: TILS). At that price, Tiziana Life Sciences would command a fully diluted market value of $212 million.  The pre-revenue company was founded in 1998 and plans to list on the Nasdaq under the symbol TLSA. Laidlaw & Company (UK) is the sole bookrunner on the deal. Deal timing was not announced. The article Antibody biotech Tiziana Life Sciences sets terms for $16 million Nasdaq IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com

[stenick] 25/9/2018 17:36

50 billion dollar market per year up for grabs.

[stenick] 30/8/2018 12:32

Found this on net about Milciclib and breast cancer.
So much reasearch with good results. Why do things take so long.
hxxps://etd.ohiolink.edu/pg_10?0::NO:10:P10_ETD_SUBID:152002

[stenick] 24/8/2018 08:08

There’s a vote of confidence!

[andrbea] 23/8/2018 13:42

The word 'spray' has made this thread exciting again:


Stenick - 16 Aug 2018 - 10:31

A nasal spray to combat Alzheimer's and others, absolutely brilliant!. This blood brain barrier seems to have been a stumbling block,but with Foralumab and Milciclib able to cross it, well what a game changers these will be and Foralumab being fully human. I'm no scientist but I can see the potential.

Stenick - 26 Apr 2018 - 07:25

We did and I think we do have a chance of a return. 25p. To 240p to 80p and lots of ups and down in between is a traders dream surely. Nothing has changed they still have some potentially really good products, loads of money, and news to come, all with less than 150mill shares in issue. The crash and Beauforts going bust has not helped the share price I suspect.
I'm still hopeful here as I like what I hear about Milciclib and the thought of using a nasal spray to combat auto immune dieseases is appealing to me let alone big pharma. I've recouped some losses and hope for a bit more here.

[stenick] 22/8/2018 07:51

Who knows Asmo but with millions of dollars,hopefully,they can get on with getting to market. And with no money issues and only 200mill shares I can see a market cap of 4 to 8 hundred million £ quite achievable to start.

[asmodeus] 22/8/2018 07:35

Then can we expect a rise on a re-start, Sten. ?

[stenick] 21/8/2018 17:56

Still along way to go to match past highs, but the day they announce offering to nasdaq there will be a halt in trading

[stenick] 21/8/2018 16:23

I did sell some holding to cover initial outlay of course.

[stenick] 21/8/2018 15:39

No Asmodeus, I bought loads at the beginning , so no averaging down, just enjoying the ride with a company I balieve in and hopefully with loads to come.

[asmodeus] 21/8/2018 14:35

Have you bought more, Stenick?

[stenick] 21/8/2018 11:06

Shareholder’s resolutions have granted that about 45million shares can be offered to high worth individuals on Nasdaq
If Tils starts at approx $2 that’s $90million dollars raised if all sold.
Plenty to finance pipeline to market.
So the higher share price we get to on Aim the the higher we start on Nasdaq, simples.

[stenick] 21/8/2018 10:53

Nasdaq listing is imminent I would imagine as it is now a more realistic price to float at, but hay onwards and upwards.